Marwood Group’s cover photo
Marwood Group

Marwood Group

Financial Services

New York City, New York 19,157 followers

About us

The Marwood Group is a healthcare focused strategic advisory and financial services firm headquartered in New York City with offices in Washington, D.C. and London. The firm has 120+ employees and provides services to institutional investors and healthcare companies. The Marwood Group believes that achieving success as an investor or operator in the healthcare industry requires a deep understanding of the complex rules and regulations that can impact business goals. The Marwood Group’s extensive track record and experience in the healthcare marketplace, coupled with its international presence, ideally positions the firm to meet the needs of its clients on a local, regional and global level. Drawing on the expertise of seasoned professionals from healthcare operations, strategic consulting, investment banking and government, Marwood advises clients on key issues affecting the healthcare industry in the United States, United Kingdom, France and Germany. Marwood offers a dynamic, fast-paced work environment for experienced professionals and recent college and master’s degree graduates. We are always looking for talented people who are passionate about healthcare to join our New York City, Washington, DC and London teams; if you want to join our team, please view our available positions on the Jobs tab.

Website
http://www.marwoodgroup.com
Industry
Financial Services
Company size
51-200 employees
Headquarters
New York City, New York
Type
Privately Held
Founded
2000
Specialties
Healthcare, Consulting, Strategy, Research, Healthcare Policy, Financial Advisory, Healthcare Reimbursement, Due Diligence, and Market Research

Locations

Employees at Marwood Group

Updates

  • 𝐌𝐚𝐫𝐰𝐨𝐨𝐝 𝐆𝐫𝐨𝐮𝐩 𝐄𝐱𝐩𝐚𝐧𝐝𝐬 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐰𝐢𝐭𝐡 𝐀𝐩𝐩𝐨𝐢𝐧𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐄𝐱-𝐅𝐃𝐀 𝐏𝐨𝐥𝐢𝐜𝐲 𝐋𝐞𝐚𝐝𝐞𝐫 𝐃𝐫. 𝐑𝐢𝐭𝐮 𝐍𝐚𝐥𝐮𝐛𝐨𝐥𝐚 Marwood Group is pleased to announce the appointment of Dr. Ritu Nalubola as Director. Dr. Nalubola brings 25 years of experience at the U.S. Food and Drug Administration, where she served in various senior leadership roles, most recently as the Associate Commissioner for Policy and the Acting Deputy Commissioner for Policy, Legislation, and International Affairs https://lnkd.in/ewwk58Cd

  • Civil Investigative Demands are on the rise and the stakes for healthcare organizations have never been higher. With the DOJ issuing record numbers of #CIDs and using AI to identify potential fraud - responding quickly and accurately is critical to avoiding financial, operational, and reputational damage. In our latest whitepaper, we show how Marwood's regulatory expertise & proprietary analytics help clients navigate CID investigations with speed, precision, and confidence. Read more: https://lnkd.in/ergH62mC

  • The new #NHS 10-Year Health Plan marks a major shift toward community care, digital infrastructure, and preventative health. Our latest whitepaper unpacks the implications for private sector providers & investors - from digital health to outpatient service - and outlines key risks & opportunities in navigating this new landscape. Read the full analysis here: https://lnkd.in/epA6hWDM

    • No alternative text description for this image
  • We're proud be to sponsoring the 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐑𝐞𝐢𝐦𝐛𝐮𝐫𝐬𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 next month! Connect with our team in Nashville to learn more about the evolving landscape of reimbursement strategy, payer engagement, and market access for innovative medical technologies. Save 20% on registration with code MARWOOD https://lnkd.in/etg-k9p5

    • No alternative text description for this image
  • 𝐌𝐚𝐫𝐰𝐨𝐨𝐝 𝐆𝐫𝐨𝐮𝐩’𝐬 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐈𝐦𝐩𝐫𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐀𝐝𝐝𝐬 𝐎𝐬𝐢 𝐔𝐝𝐞𝐳𝐢 𝐚𝐬 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫 𝐨𝐟 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐂𝐲𝐜𝐥𝐞 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 Marwood Group announced today the appointment of Osi Udezi, MHA as Director of Revenue Cycle Transformation for the Performance Improvement Practice. This practice works with leading healthcare clients to optimize financial and operational performance. This includes working with corporate healthcare clients and PE-backed healthcare companies focused on revenue enhancement initiatives, cost reduction, and operational transformation activities. "𝘈𝘯 𝘪𝘯𝘤𝘳𝘦𝘢𝘴𝘪𝘯𝘨𝘭𝘺 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭 𝘢𝘳𝘦𝘢 𝘰𝘧 𝘧𝘰𝘤𝘶𝘴 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘤𝘭𝘪𝘦𝘯𝘵 𝘳𝘦𝘮𝘢𝘪𝘯𝘴 𝘙𝘊𝘔 𝘱𝘳𝘰𝘤𝘦𝘴𝘴 𝘰𝘱𝘵𝘪𝘮𝘪𝘻𝘢𝘵𝘪𝘰𝘯, 𝘮𝘢𝘳𝘨𝘪𝘯-𝘤𝘦𝘯𝘵𝘳𝘪𝘤 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘦𝘯𝘢𝘣𝘭𝘦𝘮𝘦𝘯𝘵, 𝘢𝘯𝘥 𝘤𝘰𝘴𝘵 𝘤𝘰𝘯𝘵𝘳𝘰𝘭. 𝘈𝘴 𝘸𝘦 𝘨𝘳𝘰𝘸 𝘰𝘶𝘳 𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘵𝘰 𝘥𝘦𝘭𝘪𝘷𝘦𝘳 𝘵𝘢𝘯𝘨𝘪𝘣𝘭𝘦 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘤𝘭𝘪𝘦𝘯𝘵𝘴, 𝘸𝘦 𝘢𝘳𝘦 𝘦𝘹𝘤𝘪𝘵𝘦𝘥 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘖𝘴𝘪 𝘰𝘯 𝘵𝘰 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘵𝘩𝘪𝘴 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵 𝘸𝘰𝘳𝘬, 𝘱𝘢𝘳𝘵𝘪𝘤𝘶𝘭𝘢𝘳𝘭𝘺 𝘩𝘦𝘭𝘱𝘪𝘯𝘨 𝘤𝘭𝘪𝘦𝘯𝘵𝘴 𝘮𝘢𝘹𝘪𝘮𝘪𝘻𝘦 𝘧𝘪𝘯𝘢𝘯𝘤𝘪𝘢𝘭 𝘱𝘦𝘳𝘧𝘰𝘳𝘮𝘢𝘯𝘤𝘦 𝘪𝘯 𝘢𝘯 𝘦𝘳𝘢 𝘰𝘧 𝘤𝘰𝘯𝘵𝘳𝘢𝘤𝘵𝘪𝘯𝘨 𝘳𝘦𝘪𝘮𝘣𝘶𝘳𝘴𝘦𝘮𝘦𝘯𝘵." said Marwood’s Senior Managing Director Lee Alvarez. Mr. Udezi serves as the Director of Revenue Cycle Transformation within the Performance Improvement practice, bringing over 15 years of experience in healthcare operations and revenue cycle/financial performance optimizations. Before joining Marwood, Mr. Udezi led multiple engagements across various healthcare organizations to impact net revenue improvement through process optimization, system conversions, and overall business process and organizational transformations. His background includes pre-transaction advisory and post-transaction synergy capture for PE-backed physician and outpatient practice management, including integrating medical back-office operations for improved efficiencies, implementing best practices for improved patient access and flow across hospital departments, and enhancing financial performance through cash acceleration, net-revenue growth and cost take-out. Mr. Udezi holds a master’s degree in healthcare administration from the University of Illinois in Chicago and is a member of the American College of Healthcare Executives (ACHE) and the National Association of Health Services Executives (NAHSE) Learn more about Marwood's Performance Improvement Practice here: https://lnkd.in/e6GjwS5P

    • No alternative text description for this image

Similar pages

Browse jobs